ImageneBio (IMA) Current Deferred Revenue (2020 - 2024)
ImageneBio (IMA) posted Current Deferred Revenue of $650000.0 for Q4 2024, down 7.14% sequentially from $700000.0 in Q3 2024.
ImageneBio (IMA) Current Deferred Revenue (2020 - 2024) Analysis & Trends
ImageneBio has reported Current Deferred Revenue for 5 years, with the latest figure at $650000.0 in Q4 2024.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $650000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $650000.0 (changed N/A YoY) and the FY2024 annual result came in at $650000.0, changed N/A from the prior year.
- Current Deferred Revenue declined to $650000.0 in Q4 2024 per IMA's latest filing, from $700000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $22.6 million in Q3 2021 and troughed at $650000.0 in Q4 2024.
- A 5-year average of $12.0 million and a median of $14.4 million in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue tumbled 94.56% in 2023, then gained 6.22% in 2024.
- Over 5 years, Current Deferred Revenue stood at $20.6 million in 2020, then slipped by 17.08% to $17.1 million in 2021, then tumbled by 46.2% to $9.2 million in 2022, then slumped by 92.84% to $659000.0 in 2023, then slipped by 1.37% to $650000.0 in 2024.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $650000.0, $700000.0, and $659000.0 for Q4 2024, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 650,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2023 | 659,000.00 |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 3.85 Mn |
| Dec 31, 2022 | 9.20 Mn |
| Sep 30, 2022 | 12.11 Mn |
| Jun 30, 2022 | 17.19 Mn |
| Mar 31, 2022 | 16.75 Mn |
| Dec 31, 2021 | 17.10 Mn |
| Sep 30, 2021 | 22.57 Mn |
| Jun 30, 2021 | 22.47 Mn |
| Mar 31, 2021 | 22.34 Mn |
| Dec 31, 2020 | 20.62 Mn |